🔗 Share this article

A shadow economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Experimental Drug Acquiring Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with numerous of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing customers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be linked to the rising price of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Response and Content Removal

Based on TikTok, the platform has removed problematic content and prohibited related keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Digital Marketplace Activities

Investigations also discovered groups with up to nine thousand members marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, populated with photos of weight loss, positive testimonials and detailed instructions for mixing or injecting at home.

After moments of entering one group, a vendor posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially serious medical dangers”.